NOVAREX Co.,Ltd. (KOSDAQ:194700)

South Korea flag South Korea · Delayed Price · Currency is KRW
17,620
+300 (1.73%)
Last updated: Oct 30, 2025, 11:41 AM KST
1.73%
Market Cap308.02B
Revenue (ttm)349.19B
Net Income (ttm)27.12B
Shares Out17.70M
EPS (ttm)1,532.00
PE Ratio11.36
Forward PEn/a
Dividend200.00 (1.15%)
Ex-Dividend DateDec 27, 2024
Volume101,209
Average Volume244,149
Open17,600
Previous Close17,320
Day's Range17,300 - 18,100
52-Week Range6,650 - 22,100
Beta0.30
RSI41.75
Earnings DateNov 14, 2025

About NOVAREX

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science Co., Ltd. and changed its name to NOVAREX Co.,Ltd. in November 2013. NOVAREX Co.,Ltd. was founded in 1995 and is headquartered in Cheongju-si, South Kor... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 430
Stock Exchange KOSDAQ
Ticker Symbol 194700
Full Company Profile

Financial Performance

In 2024, NOVAREX's revenue was 297.73 billion, a decrease of -1.47% compared to the previous year's 302.17 billion. Earnings were 23.02 billion, an increase of 4.45%.

Financial Statements

News

There is no news available yet.